F584-1319 Screening compound: ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}benzoate

F584-1319 Screening compound: ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}benzoate
F584-1319 Screening compound: ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F584-1319
ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F584-1319

Molecular Formula

C23H29N5O4 (C23 H29 N5 O4)

Compound Name

ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}benzoate

IUPAC name

ethyl 4-{[1-methyl-3-(piperidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]amino}benzoate

SMILES

CCOC(c(cc1)ccc1NC(N(CC1)Cc2c1n(C)nc2C(N1CCCCC1)=O)=O)=O

InChI

InChI=1S/C23H29N5O4/c1-3-32-22(30)16-7-9-17(10-8-16)24-23(31)28-14-11-19-18(15-28)20(25-26(19)2)21(29)27-12-5-4-6-13-27/h7-10H,3-6,11-15H2,1-2H3,(H,24,31)

InChI Key

FNDIUHRNLHWSIX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27177385

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.348

Distribution Coefficient, logD

2.348

Water Solubility, LogSw

-2.81

Polar Surface Area

77.789

Acid Dissociation Constant (pKa)

12.38

Base Dissociation Constant (pKb)

9.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.80

F584-1319 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Hsp90-Targeted Library (11355 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with F584-1319 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F584-1319?
Check Price and Availability of F584-1319, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F584-1319 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F584-1319
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F584-1319
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F584-1319 available by request